about
Cu to Zn ratio, physical function, disability, and mortality risk in older elderly (ilSIRENTE study).Underuse of lipid-lowering drugs and factors associated with poor adherence: a real practice analysis in Italy.Different aspects of adherence to antihypertensive treatments.Variability in the prescription of cardiovascular medications in older patients: correlates and potential explanations.Opioids for the treatment of chronic non-cancer pain in older people.Targeting inflammation to slow or delay functional decline: where are we?Frailty and muscle metabolism dysregulation in the elderly.Moving against frailty: does physical activity matter?Comorbidities of chronic obstructive pulmonary disease.The economic burden of chronic obstructive pulmonary disease in the elderly: results from a systematic review of the literature.The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review.Special considerations for the treatment of chronic kidney disease in the elderly.Advanced technology care innovation for older people in Italy: necessity and opportunity to promote health and wellbeing.Does concealed chronic kidney disease predict survival of older patients discharged from acute care hospitals?The pharmacoeconomic impact of amlodipine use on coronary artery disease.The UP-TECH project, an intervention to support caregivers of Alzheimer's disease patients in Italy: preliminary findings on recruitment and caregiving burden in the baseline population.Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA.Coronary flow response to remote ischemic preconditioning is preserved in old cardiac patients.Depression, hypertension, and comorbidity: disentangling their specific effect on disability and cognitive impairment in older subjects.Selenium Concentrations and Mortality among Community-Dwelling Older Adults: Results from IlSIRENTE StudyThe Possible Impact of Aortic Stiffness on Quality of Late Life: An Exploratory Study
P50
Q35916426-25C8C2E4-9BF1-44F7-B142-A9F98C43376DQ36095808-00047084-C571-432F-8A87-86AFBD4C7287Q37609194-BFA6E83A-6B77-45DF-A7EE-86F5AE6DDF12Q37688028-4B8AC4ED-CF3A-4B68-A16C-A0EBC8C2EDA0Q37688035-F69E9F8F-DA23-4460-81CA-05DC316FC17FQ37765193-DE42386E-1CFB-42D6-9C8E-CA0680DA4535Q37777665-A8E21473-1AFE-4AD8-9E57-4A951027883BQ37779032-CA61DAB3-AE16-4160-9FFB-8D3FB2FC43ABQ37972495-9CFDD574-193B-488E-AEF5-07F3AB594503Q37972498-07A81F80-F988-41F7-857E-83D220CFC21BQ38085227-2DC1035B-AF87-44C0-AB49-4D9B53D0BC2AQ38737061-3D634F71-1FA3-4EAF-B0B3-E2B24CC1D826Q39190779-F0D8F7BC-C61C-4CC0-B990-770756F5279EQ42835528-51591D31-1AAC-4361-8632-E3B7726BB0A7Q43789662-5DEA7FDA-6861-4557-A97F-DB716C218DBAQ45894235-0DD43152-F780-4416-B597-71ADCF739D39Q46889924-018BA1AF-B3D9-4986-BC8B-8BD61E3FADA4Q50101215-86C635B2-A187-41EB-A0E6-D136B4326345Q51852403-846DBE96-FDAD-4335-8ACE-381B4E2C2EDEQ88539794-835FADDA-4FE8-446F-8A45-A001BC64CC0DQ89883380-521A94E3-CA5E-494D-935A-801D6AD83DC4
P50
description
researcher ORCID ID = 0000-0002-8166-3265
@en
wetenschapper
@nl
name
Silvia Bustacchini
@ast
Silvia Bustacchini
@en
Silvia Bustacchini
@es
Silvia Bustacchini
@nl
type
label
Silvia Bustacchini
@ast
Silvia Bustacchini
@en
Silvia Bustacchini
@es
Silvia Bustacchini
@nl
prefLabel
Silvia Bustacchini
@ast
Silvia Bustacchini
@en
Silvia Bustacchini
@es
Silvia Bustacchini
@nl
P106
P1153
35794883400
P21
P31
P496
0000-0002-8166-3265